CClinicalTrials.gg
CompletedNCT01013896BALANCEUpdated Mar 31, 2015

Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience

An interventional study of Motivational Interviewing and Cystic Fibrosis Education in Cystic Fibrosis, sponsored by Johns Hopkins University. Completed at 1 site in United States. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2015-03-31.

Sponsored by Johns Hopkins University · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The investigators research group and others have found that patient-reported adherence to all aspects of the regimen is suboptimal and objective measures suggest even poorer adherence. There is little data, however that identifies and examines the reason for nonadherence in an adult Cystic Fibrosis (CF) population or identifies effective strategies for improving adherence.

The investigators propose to evaluate the relative efficacy of a Motivational Interviewing-focused intervention (MI) in improving adherence and reducing CF-related morbidity compared to a CF education intervention (CFE; attention control group). Specifically, The investigators hypothesize that MI will result in improved regimen adherence and reduced CF morbidity compared to the CFE control group.

02

Conditions studied

  • Cystic Fibrosis
03

In context

Cystic Fibrosis

1,581 studies on the registry are indexed under Cystic Fibrosis; 190 are open to participants now.

This study's enrollment of 128 is above the median of 36 across 1,034 interventional studies indexed under Cystic Fibrosis.

Browse Cystic Fibrosis studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Have a doctor confirmed diagnosis of CF
  • Age 16 years old or older
  • Prescribed an inhaled mucolytic, inhaled antibiotic therapy, chronic macrolide therapy and/or hypertonic saline therapy for the previous 12 months.
  • Scheduled for a regular visit at either the pediatric or the adult CF clinic at Johns Hopkins Hospital.

Exclusion criteria

Exclusion Criteria:

  • Burkholderia cepacia complex isolated from the respiratory tract within the past 2 years.
  • Had a lung transplant
  • Participated in NA_00008649 A pilot study of Motivational Interviewing for adults with CF.
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
128 participants (actual)

Study arms

  • Active comparator
    Cystic Fibrosis Education

    This intervention is designed to increase knowledge and enhance the skills needed to optimize CF-management. The strategies used to achieve improved adherence include providing didactic education and skills training, and proscriptively using behavioral modification strategies, such as positive reinforcement for desired behaviors, and problem-solving training to overcome barriers.

    Other: Cystic Fibrosis Education

  • Experimental
    Motivational Interviewing

    The Counselor's overarching goal for the intervention is to motivate and assist the participant to improve his/her adherence to the CF pulmonary medications. The intervention will begin by providing the patient personal feedback on their adherence (using pharmacy refill data) and health outcomes (e.g., trajectory of lung function values, frequency of exacerbations) as well as clinic-level figures showing the association between adherence and health outcomes.

    Behavioral: Motivational Interviewing

Interventions

  • BehavioralMotivational Interviewing

    Among a group of older adolescents and adults with CF, we propose to evaluate the relative efficacy of a Motivational Interviewing-focused intervention (MI) in improving adherence and reducing CF-related morbidity compared to a CF education intervention (CFE; attention control group).

  • OtherCystic Fibrosis Education

    Among a group of older adolescents and adults with CF, we propose to evaluate the relative efficacy of a Motivational Interviewing-focused intervention (MI) in improving adherence and reducing CF-related morbidity compared to a CF education intervention (CFE; attention control group). The Cystic Fibrosis Education serves as the attention control group.

06

What researchers measure

Primary outcomes

  1. A medication possession ratio (MPR) will be calculated for each prescribed drug that is being monitored for adherence.

    Time frame: 12 months

Secondary outcomes

  1. Change in Forced Expiratory Volume in One Second (FEV1) Percent Predicted.

    Time frame: 12 months

07

Study locations

1 site
  • Johns Hopkins
    Baltimore, Maryland 21224, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01013896
Lead sponsor
Johns Hopkins University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Kristin A. Riekert, PhD (Co-Director, The Johns Hopkins Adherence Research Center, Johns Hopkins University) — Principal investigator
First posted
Nov 16, 2009
Start date
Jul 2009
Primary completion
Jan 2014
Completion
May 2014
Last update
Mar 31, 2015

Study contacts

Kristin A Riekert, Ph.D.
principal investigator · The Johns Hopkins Adherence Research Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion